Drugs that contain Zolmitriptan
1. Zomig patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5466699 | AMNEAL | Indolyl compounds for treating migraine |
Nov, 2012
(11 years ago) | |
|
US5466699 (Pediatric) | AMNEAL | Indolyl compounds for treating migraine |
May, 2013
(10 years ago) | |
| US6750237 | AMNEAL | Pharmaceutical formulations containing zolmitriptan |
Nov, 2020
(3 years ago) | |
| US7220767 | AMNEAL | Pharmaceutical formulations containing zolmitriptan |
Nov, 2020
(3 years ago) | |
|
US6750237 (Pediatric) | AMNEAL | Pharmaceutical formulations containing zolmitriptan |
May, 2021
(2 years ago) | |
|
US7220767 (Pediatric) | AMNEAL | Pharmaceutical formulations containing zolmitriptan |
May, 2021
(2 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Jun 12, 2018 |
Market Authorisation Date: 16 September, 2013
Treatment: Acute treatment of migraine attacks with or without aura in adults
Dosage: SPRAY;NASAL
How can I launch a generic of ZOMIG before it's drug patent expiration?
More Information on Dosage
ZOMIG family patents
2. Zomig patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5863935 | IPR | Therapeutic heterocyclic compounds |
Nov, 2012
(11 years ago) | |
| US5466699 | IPR | Indolyl compounds for treating migraine |
Nov, 2012
(11 years ago) | |
|
US5863935 (Pediatric) | IPR | Therapeutic heterocyclic compounds |
May, 2013
(10 years ago) | |
|
US5466699 (Pediatric) | IPR | Indolyl compounds for treating migraine |
May, 2013
(10 years ago) | |
Market Authorisation Date: 25 November, 1997
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of ZOMIG before it's drug patent expiration?
More Information on Dosage
ZOMIG family patents
3. Zomig-zmt patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5466699 | ASTRAZENECA | Indolyl compounds for treating migraine |
Nov, 2012
(11 years ago) | |
|
US5466699 (Pediatric) | ASTRAZENECA | Indolyl compounds for treating migraine |
May, 2013
(10 years ago) | |
Market Authorisation Date: 13 February, 2001
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
ZOMIG-ZMT family patents